BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2024

Nov 14, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2024-11-12

Reporting Person: Guyer Charles Greg (EVP, Chief Technical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-10-31	Common Stock	A	55	$56.007	Acquired	74187	Direct
2024-11-12	Common Stock	S	5278	$66.3743	Disposed	68909	Direct

Footnotes

F1: Represents the shares acquired by the reporting person on October 31, 2024, pursuant to the issuer's Employee Stock Purchase Plan.

F2: The price in column 4 is the weighted average price. The purchase price actually received ranged from $66.37 to $66.395. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.